0.1053 USD
-0.02 (-17.8%)
0.12 USD
+0.01 (+13.96%)
ChartMill assigns a Buy % Consensus number of 83% to NMRD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.67. This target is 8133.62% above the current price.
NMRD was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about NMRD.
In the previous month the buy percentage consensus was at a similar level.
NMRD was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-08-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-07-17 | EF Hutton | Maintains | Buy -> Buy |
| 2023-03-30 | EF Hutton | Reiterate | Buy |
| 2023-02-28 | EF Hutton | Maintains | Buy |
| 2023-02-27 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-19 | HC Wainwright & Co. | Maintains | Buy |
| 2021-12-02 | EF Hutton | Initiate | Buy |
NEMAURA MEDICAL INC / NMRD FAQ
What do analysts expect the price target to be for NEMAURA MEDICAL INC (NMRD)?
7 analysts have analysed NMRD and the average price target is 8.67 USD. This implies a price increase of 8133.62% is expected in the next year compared to the current price of 0.1053.
What is the consensus rating for NMRD stock?
The consensus rating for NEMAURA MEDICAL INC (NMRD) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed NEMAURA MEDICAL INC (NMRD)?
The number of analysts covering NEMAURA MEDICAL INC (NMRD) is 7.